logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Feng Zhang

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 9.8

ph-index = 7

Forward Citations = 255(Granted Patents)


Company Filing History:

goldMedal12 out of 197 
 
Senomyx, Inc.
 patents

Years Active: 2011-2018

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 9902737 - Sweet flavor modifier (2018-02-27),
2. 9834544 - Sweet flavor modifier (2017-12-05),
3. 9603848 - Modulation of chemosensory receptors and ligands associated therewith (2017-03-28),
4. 9181276 - Modulation of chemosensory receptors and ligands associated therewith (2015-11-10),
5. 9049878 - Sweet flavor modifier (2015-06-09),
6. 8815956 - Sweet flavor modifier (2014-08-26),
7. 8633186 - Modulation of chemosensory receptors and ligands associated therewith (2014-01-21),
8. 8592592 - Sweet flavor modifier (2013-11-26),
9. 8541421 - Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidines (2013-09-24),
10. 8247184 - Assays using chimeric T1R polypeptides for identifying putative taste modulatory compounds (2012-08-21),
11. 7928111 - Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors (2011-04-19),
12. 7906627 - Chimeric human sweet-umami and umami-sweet taste receptors (2011-03-15),

Title: The Innovative Journey of Inventor Feng Zhang

Introduction: Feng Zhang is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to the field of biotechnology and genetic engineering.

Latest Patents: Feng Zhang holds several patents related to CRISPR-Cas9 gene editing technology, including patents for novel applications in agriculture, medicine, and biotechnology.

Career Highlights: With a background in bioengineering and molecular biology, Feng Zhang has made significant strides in developing CRISPR-based tools for precise genome editing, earning him recognition as one of the leading innovators in the field.

Collaborations: Feng Zhang has collaborated with top research institutions, biotech companies, and universities worldwide to further explore the potential of CRISPR technology in various industries, fostering a culture of innovation and collaboration.

Conclusion: Feng Zhang's pioneering work in the field of genetic engineering continues to inspire new advancements and applications, shaping the future of biotechnology and precision medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…